New blood test could streamline Alzheimer’s diagnosis and treatment access

Scientists at CSIRO, Australia’s national science agency, have identified simpler and less invasive methods to improve Alzheimer’s disease diagnosis, potentially making it easier for patients to access emerging treatments.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup